Meropenem Fresenius Kabi

Meropenem, the active ingredient in Meropenem Fresenius Kabi, is a carbapenem antibiotic presented as a powder for solution for injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, bacterial meningitis, pneumonia, sepsis and septic shock in hospitalized patients.

GNH USA supplies Meropenem Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious infections caused by susceptible bacteria.

Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure. Complicated urinary tract infections: resolves infection and prevents spread. Bacterial meningitis: achieves rapid bacterial clearance in the central nervous system. Severe community‑acquired or hospital‑acquired pneumonia: improves survival and resolves pulmonary infection. Sepsis and septic shock caused by susceptible organisms: supports hemodynamic stabilization and infection control.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Vomiting - Headache - Rash - Elevated liver enzymes

Serious or Rare Side Effects: - Anaphylaxis - Stevens‑Johnson syndrome - Seizures, especially in patients with renal impairment - Clostridioides difficile‑associated colitis - Hemolytic anemia - Severe neutropenia

When using Meropenem, clinicians should consider several safety measures.

Renal function: adjust dose in patients with impaired kidney function. Hypersensitivity: discontinue if signs of allergic reaction appear. Seizure risk: monitor patients with central nervous system disorders or high doses. Clostridioides difficile infection: use only when necessary to reduce risk of colitis. Pregnancy and lactation: use only if benefits outweigh potential risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; some combinations require avoidance, others close monitoring.

Major Interactions (Avoid): - Valproic acid: may reduce serum valproate levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, raising toxicity potential. - Aminoglycosides: concurrent use may increase nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may affect renal clearance of meropenem. - Anticoagulants (e.g., warfarin): possible alteration of INR values. - Oral contraceptives: may experience reduced efficacy.